US Patent 10259870 Anti-ANGPTL8 antibodies and uses thereof
Patent 10259870 was granted and assigned to Regeneron Pharmaceuticals on April, 2019 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
August 4, 2016
0
Date of Patent
April 16, 2019
0
Patent Applicant
Patent Application Number
15228398
0
Patent Citations Received
Patent Inventor Names
David R. Buckler
0
Andrew J. Murphy
0
Jesper Gromada
0
Viktoria Gusarova
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10259870 Anti-ANGPTL8 antibodies and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
